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Intimate partner violence is a serious global problem that damages the health and prosperity of individuals, their
families, community, and society. WHO endorses an ‘ecological model,’ which states that there are multi-level
intersecting factors enabling perpetration and victimization of violence. Intervention science to prevent or reduce
the problem is in its infancy, and the few existing intervention studies have been targeted at the individual level. In
a recent study published in BMC Medicine, Abramsky et al. bring innovation to the field, targeting their intervention
trial “SASA!” in Kampala Uganda at all ecological levels, but particularly at the community level. Recruiting and
training both male and female community leaders and activists who enabled group and media discussions, the
authors focused on the beneficial and abusive detrimental uses of power rather than commencing with the
central issue of gender inequality. SASA! successfully reduced community attitudes to tolerance of violence and
inequality, men’s sexual risk behaviors, and women’s experience of physical violence. The study also improved the
communities’ response to victimized women. SASA! has promise for adaptation and replication in low, middle and
high income countries.
Please see related article: http://www.biomedcentral.com/1741-7015/12/122.
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Gender-based violence, especially its most common form –
intimate partner violence (IPV) – is prevalent globally.
Evidence that such violence causes serious health dam-
age to women, their children, families, and society is
now overwhelming [1]. It can be particularly harmful to
the health and development of low and middle income
countries (LMIC), for example, affecting maternal mor-
bidity and mortality rates, and the levels of HIV infec-
tion among women and children. In an article recently
published in BMC Medicine, Abramsky et al. demon-
strated innovation in methods for pragmatic random-
ized trials for the prevention of gender-based violence
[2]. In doing so, they advanced the very small evidence
base of effective interventions to prevent and reduce the
level of IPV and sexual violence against women and the
consequences of such violence.
The World Health Organization (WHO) recently pub-
lished a strategic framework for preventing and reducing* Correspondence: a.taft@latrobe.edu.au
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unless otherwise stated.violence against women [3]. In doing so, WHO drew on
an ‘ecological model’ of factors (below, Figure 1), which
illustrates the intersecting determinants of IPV that can
influence the likelihood that men will abuse women and
women will become victimized.
The factors related to both victimization and perpetra-
tion, and therefore to finding solutions to IPV, are located
at the level of the individual (for example, witnessing
abuse as a child; drinking alcohol at harmful levels), the
relationship (for example, men controlling financial re-
sources or having multiple partners); the community (high
poverty or unemployment levels, weak community sanc-
tions) and society (for example, norms of masculinity in-
cluding dominance and aggression; the absence of legal
sanction or redress against gender-based violence) [3].
In the SASA! Study, Abramsky et al. identified gender
inequality and the consequent power imbalance between
women and men as central to an environment in which
violence against women can flourish [2]. They understood
the need for the development and rigorous evaluation of
interventions to prevent and reduce IPV and sexual vio-
lence against women at all levels of the WHO model, andal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The ecological model. Reproduced from [3] with permission from the World Health Organisation.
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community level. The authors of the WHO Prevention re-
port reviewed the current evidence for effective interven-
tions to prevent and reduce partner violence, and found it
to be very inadequate. The authors (p.1) concluded that
‘The primary prevention of these types of violence will …
save lives and money – investments made now to stop
IPV and sexual violence before they occur will protect
the physical, mental and economic well-being and de-
velopment of individuals, families, communities and
whole societies’ [3].
There have been several systematic reviews of partner
violence interventions, predominantly targeted at indi-
viduals, for example, using advocacy [4] or using clin-
ician practices such as screening for partner violence in
healthcare settings [5]. Such reviews have also found the
evidence base to be small. In addition, the majority of
the evidence comes from high income countries (HIC),
notably the USA, and may therefore not be applicable in
resource-poor countries. From existing studies, there is
some evidence that advocacy (providing identified indi-
vidual women victims/survivors with information and
support) can improve women’s health and well-being;
that psychological interventions (for example, psycho-
therapeutic methods) can improve pregnant women’s
outcomes [6]; and that interventions by primary care
clinician may increase identification, referrals, and de-
pression [7,8].
Rigorously developed and evaluated interventions on
IPV in LMIC are very few, but those that exist have
taken a broader perspective focused on known determi-
nants of partner abuse or on implemented and innova-
tive approaches to social support. These have targeted
individual women, for example, initiatives aimed at build-
ing alliances between mothers-in-law and daughters-in-
law in India to stop abuse of pregnant and post-partum
women [9]; micro-financing and gender and advocacy
training [10]; and tackling gender norms and economic
empowerment [11].
The innovation that SASA! [2] (Start, Awareness,
Support, Action!), a cluster randomized trial conducted
in Kampala, Uganda has successfully demonstrated is
that it is possible to change gender norms and attitudesby targeting interventions to reduce partner violence
and HIV behaviors at the community level. SASA! used
the ecological model above as an intervention frame-
work (targeting societal, community, relationship, and
individual attitudes and practices). It aimed to engage
not only women but also men (involving many degrees
of difficulty in attempting to change male and female at-
titudes and behaviors). Working to identify community
leader/partners and to build alliances is a marathon ef-
fort, and the fruits of these efforts can also take time to
appear. There were other challenges; for example, dur-
ing the trial implementation, political conflict and elec-
tions in Uganda interrupted the activities, and the study
had to be suspended for a time.
The major strategies in SASA! involved training male
and female community leaders and community activists in
the four intervention communities, after which the partic-
ipants engaged in critical discourse in the community
media and with community groups about power and
power inequalities. Their message was not only how
power can be abused. but also how it can be used posi-
tively for beneficial change. The pre-defined primary out-
comes included: 1) reduced social acceptance of gender
inequality and IPV; 2) decrease in experience of IPV; 3)
improved (community) response to women experiencing
violence; and 4) decrease in sexual risk behaviors. High
rates of activity, participation, and improved community
response to violence led to significant reductions in the
acceptance of men’s use of violence and increased accept-
ance of a woman’s right to refuse sex in intervention com-
munities. Men’s concurrent sexual partners (a risk factor
for HIV infection) and women’s experience of physical
violence in the past year were also reduced.
The SASA! study authors argue that these effects at
community level, not limited to people with high levels
of exposure, attest to the diffusion that can occur in
communities and the importance of community-level
studies. An improved response to victimized women at
community level consolidates this. The study acknowl-
edged some limitations (potential contamination that
might have weakened effects, and issues of population
mobility); nevertheless this should not diminish the im-
portance of the outcomes achieved.
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This trial will hopefully stimulate further community-
level intervention studies in other LMIC, and indeed
also in HIC, where individual approaches have been
more common and have proved inadequate to date. Im-
portantly for future research, the involvement in SASA!
of male as well as female advocates to challenge attitudes
to power and partner violence, proved both innovative
and effective in reducing violence. Reducing IPV and other
forms of gender-based violence will improve the health,
social welfare, and economy, particularly of LMIC.
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